Literature DB >> 18845252

The permeability of large molecular weight solutes following particle delivery to air-interfaced cells that model the respiratory mucosa.

C I Grainger1, L L Greenwell, G P Martin, B Forbes.   

Abstract

The transepithelial transport rates of compounds after deposition as aerosolised particles onto respiratory cell layers and allowing dissolution in the cell surface secretions has not been reported in a comprehensive manner to date. Here, the twin-stage impinger (TSI) was used to deposit potentially respirable particles (aerodynamically <6.4 microm) of varying molecular weight dextrans labelled with fluorescein isothiocyanate (FITC-dex) onto Calu-3 cells, a model of the bronchial epithelium. The TSI functioned as a particle size segregator, with >96% of the deposited particles being geometrically <6.4 microm (as measured by microscopy) and the particles being deposited discretely with a uniform distribution. Cell layers tolerated particle deposition at an air flow of 60 L/min. A small reduction in transepithelial electrical resistance (TER) of <10% occurred initially, but the original TER was recovered within 10 min and there was no significant effect on apparent permeability (P(app)) of FITC-dex 4 over 4 h. Interleukin 8 (IL-8) secretion in the apical and basolateral directions over 24 h was not increased by exposure to the TSI and particle deposition. The rate of FITC-dex 4 (4 kDa) transport across the cell layer after deposition and dissolution of the particles in the cell surface secretions was approximately 20-fold higher (P<0.05) than if applied as a solution. The volume of cell surface secretions was estimated by tracer dilution (3.44+/-1.90 microl, mean+/-SEM) and this value was used to calculate the P(app) of compound once deposited as a particle. The Papp value was found to be similar to that obtained when the compound was applied in solution (P<0.05). Thus, the increased transport rate was attributable to the differences in donor chamber solute concentration rather than any change in the permeability of the cell layer itself. Following particle deposition, transport of FITC-dex with molecular weights between 4 and 70 kDa correlated well (r(2)=0.918) with reported in vivo canine pulmonary clearance after intratracheal instillation of dextrans of similar molecular weight. The use of the TSI and the Calu-3 cell line for the assessment of compound dissolution and transport rates after particle deposition may allow more realistic analyses to be made with respect to the in vivo situation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18845252     DOI: 10.1016/j.ejpb.2008.09.006

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  20 in total

1.  Drug Permeation Characterization of Inhaled Dry Powder Formulations in Air-Liquid Interfaced Cell Layer Using an Improved, Simple Apparatus for Dispersion.

Authors:  Ayumu Asai; Tomoyuki Okuda; Erina Sonoda; Tomoyo Yamauchi; Saki Kato; Hirokazu Okamoto
Journal:  Pharm Res       Date:  2015-10-21       Impact factor: 4.200

Review 2.  Challenges with developing in vitro dissolution tests for orally inhaled products (OIPs).

Authors:  Trevor Riley; David Christopher; Jan Arp; Andrea Casazza; Agnes Colombani; Andrew Cooper; Monisha Dey; Janet Maas; Jolyon Mitchell; Maria Reiners; Nastaran Sigari; Terrence Tougas; Svetlana Lyapustina
Journal:  AAPS PharmSciTech       Date:  2012-07-14       Impact factor: 3.246

3.  Epithelial profiling of antibiotic controlled release respiratory formulations.

Authors:  Hui Xin Ong; Daniela Traini; Mary Bebawy; Paul Michael Young
Journal:  Pharm Res       Date:  2011-05-26       Impact factor: 4.200

4.  Modification of disodium cromoglycate passage across lung epithelium in vitro via incorporation into polymeric microparticles.

Authors:  Mehra Haghi; Rania Salama; Daniela Traini; Mary Bebawy; Paul M Young
Journal:  AAPS J       Date:  2011-12-28       Impact factor: 4.009

5.  Sweetening Inhaled Antibiotic Treatment for Eradication of Chronic Respiratory Biofilm Infection.

Authors:  Ching-Yee Loo; Wing-Hin Lee; Gianluca Lauretani; Santo Scalia; David Cipolla; Daniela Traini; Paul Young; Hui Xin Ong
Journal:  Pharm Res       Date:  2018-02-07       Impact factor: 4.200

6.  Formulation and evaluation of carrier-free dry powder inhaler containing sildenafil.

Authors:  Thi-Tram Nguyen; Eun-Jin Yi; Kyu-Mok Hwang; Cheol-Hee Cho; Chun-Woong Park; Ju-Young Kim; Yun-Seok Rhee; Eun-Seok Park
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

7.  In vitro cell integrated impactor deposition methodology for the study of aerodynamically relevant size fractions from commercial pressurised metered dose inhalers.

Authors:  Mehra Haghi; Daniela Traini; Paul Young
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

8.  Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia.

Authors:  Hui Xin Ong; Daniela Traini; David Cipolla; Igor Gonda; Mary Bebawy; Helen Agus; Paul M Young
Journal:  Pharm Res       Date:  2012-07-26       Impact factor: 4.200

9.  Polymeric nanocarriers for transport modulation across the pulmonary epithelium: dendrimers, polymeric nanoparticles, and their nanoblends.

Authors:  Balaji Bharatwaj; Radovan Dimovski; Denise S Conti; Sandro R P da Rocha
Journal:  AAPS J       Date:  2014-04-02       Impact factor: 4.009

10.  A dose-controlled system for air-liquid interface cell exposure and application to zinc oxide nanoparticles.

Authors:  Anke Gabriele Lenz; Erwin Karg; Bernd Lentner; Vlad Dittrich; Christina Brandenberger; Barbara Rothen-Rutishauser; Holger Schulz; George A Ferron; Otmar Schmid
Journal:  Part Fibre Toxicol       Date:  2009-12-16       Impact factor: 9.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.